ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

Clinical trial NCT01600079 · COMPLETED

Trial details

NCT number: NCT01600079
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Herpes Zoster Shingles

Start date: 2012-05-15
Primary completion: 2020-10-16
Enrollment: 1505647

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.